Unravelling multiple ligand-activation binding sites using RASSL receptors

This publication has 14 references indexed in Scilit:

• A Single Mutation in the 5-HT4 Receptor (5-HT4-R D100(3.32)A) Generates a Gs-coupled Receptor Activated Exclusively by Synthetic Ligands (RASSL)
  Published by Elsevier ,2003
• Engineering receptors activated solely by synthetic ligands (RASSLs)
  Trends in Pharmacological Sciences, 2001
• Modification of the β2-Adrenergic Receptor to Engineer a Receptor-Effector Complex for Gene Therapy
  Published by Elsevier ,2001
• Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
  The FASEB Journal, 2001
• Diverse signalling by 5-hydroxytryptamine (5-HT) receptors
  Biochemical Pharmacology, 2000
• Heterogeneous ligand-mediated Ca++ responses at wt and mutant α2A-adrenoceptors suggest multiple ligand activation binding sites at the α2A-adrenoceptor
  Neuropharmacology, 2000
• Disparate ligand‐mediated Ca²⁺ responses by wild‐type, mutant Ser²⁰⁰Ala and Ser²⁰⁴Ala α_2A‐adrenoceptor : G_α15 fusion proteins: evidence for multiple ligand‐activation binding sites
  British Journal of Pharmacology, 2000
• Three-dimensional Models of α2A-Adrenergic Receptor Complexes Provide a Structural Explanation for Ligand Binding
  Journal of Biological Chemistry, 1999
• Controlling signaling with a specifically designed G _i -coupled receptor
  Proceedings of the National Academy of Sciences, 1998
• Structural basis of β‐adrenergic receptor function
  The FASEB Journal, 1989